“We’re in an exciting time right now scientifically. It’s critical to put great minds together in the same place to talk about new technologies, new devices, new therapeutics that are in development. We need to capitalize on that cooperation so we move the needle more quickly and get new therapeutics to patients who desperately need them.”

“I have been an investor in various respiratory companies over the years and believe that the respiratory space continues to be an area with significant unmet needs. With an aging demographic and growing populations around the world, the number of patients impacted by respiratory diseases only continues to increase, and I believe in the importance of continuing to innovate in this space.”